





Originally published as: 
 
Neuhauser, H.K., Lempert, T. 
Vertigo: Epidemiologic aspects 

















































Vertigo: Epidemiologic Aspects 
 
Hannelore K. Neuhauser, M.D., M.P.H.,1,2 and Thomas Lempert, M.D.2,3 
 
1Department of Epidemiology, Robert Koch Institute, Berlin, Germany  
2Department of Neurology, Vestibular Research Group, Charite´, Berlin, Germany  





Vertigo is a frequent symptom in the general population with a 12-month prevalence of 5% and an 
incidence of 1.4% in adults. Its prevalence rises with age and is about two to three times higher in 
women than in men. The epidemiology of vertigo and underlying specific vestibular disorders is still an 
underdeveloped field despite its usefulness for clinical decision making and its potential for improving 
patient care. In this article, the authors give an overview on the epidemiology of vertigo as a symptom 
and of four specific vestibular disorders: benign paroxysmal positional vertigo (BPPV), vestibular 




Epidemiologic data on vertigo and on specific vestibular syndromes are used for evidence-based 
clinical decision making,1 and are therefore valuable for clinicians and not only for public health 
experts. Furthermore, the investigation of vestibular disorders in the larger context of populations can 
contribute to a better understanding of causative factors, unravel unbiased information on outcome 
and prognosis, and point toward problems in the delivery of care. In addition, unselected vertigo 
patients from epidemiologic studies may be much more similar to the patients seen by most 
neurologists than are the highly selected patients from Dizziness Clinic case series. Finally yet 
importantly, epidemiologic data on risk factors for vestibular disorders can help generate new 
pathophysiologic hypotheses and may ultimately help improve therapy.  
 
Data on the epidemiology of vertigo, however, are scarce; one of the underlying reasons is that vertigo 
is a subjective symptom and difficult to define. The Hearing and Equilibrium Committee of the 
American Academy of Otolaryngology-Head and Neck Surgery has defined vertigo as ‘‘the sensation 
of motion when no motion is occurring relative to earth’s gravity.’’2 Although patients and many 
physicians tend to use the terms vertigo and dizziness interchangeably, dizziness experts seek to 
differentiate vertigo—as a symptom that arises from the vestibular system—from nonvestibular 
dizziness, which can comprise a sensation of light-headedness, giddiness, unsteadiness, drowsiness, 
or impeding faint. In this 
article, we use the term vertigo as a vestibular symptom. As measures of disease frequency in the 
population we use incidence (proportion of newly developed— incident—disease over a specific 
period) and prevalence (proportion of an existing disease at one time point, point prevalence, or during 
a given period, period prevalence, e.g., one-year prevalence). Lifetime prevalence denotes the 
cumulative lifetime frequency of a disease to the present time, i.e., the proportion of people who have 
had the event at any time in the past.  
 
This review will focus on the frequency and distribution of the vestibular symptom vertigo, and of four 
specific vestibular disorders, and will report recent findings on associated risk factors and personal 
and health care impact. 
 
 
Epidemiology of Vertigo 
 
The epidemiology of vertigo as a symptom reveals the true size and distribution of the disease burden 
caused by vestibular disorders. This disease burden would be largely underestimated if we would 
merely add up the data available on specific vestibular diagnoses, the most frequent of which are 





Prevalence, Incidence, and Demographic Factors 
 
Dizziness (including vertigo and nonvestibular dizziness) ranks among the most common complaints 
in medicine, affecting _20 to 30% of the general population.7–9 Surprisingly, rotatory dizziness, which 
may be interpreted as vertigo, has also been reported in up to 20 to 30% of adults in population-based 
questionnaire studies,8–10 but various methodologic factors may lead to this high prevalence, 
including suggestibility of a rotatory sensation and lack of a defined threshold (Should ‘‘a little dizzy’’ 
be counted as dizzy?). The question how frequent vestibular vertigo is at the population level was 
answered recently by means of a population survey by validated neurotologic interviews performed in 
Germany.11 This study combined a screening of a representative National Health Survey general 
population sample (n¼4,869) for moderate or severe dizziness or vertigo with detailed validated 
neurotologic interviews (n¼1003), which included an interactive part similar to a clinical situation and 
detailed standardized questions. Each participant was classified by at least two raters. Vestibular 
vertigo was defined as rotational vertigo (illusion of self-motion or object motion), positional vertigo 
(vertigo or dizziness precipitated by changes of head position, such as lying down or turning in bed) or 
recurrent dizziness with nausea and oscillopsia or imbalance. The lifetime prevalence of vertigo in 
adults aged 18 to 79 was 7.4%, the one-year prevalence 4.9%, and the one-year incidence 1.4% 
(Table 1). Vestibular vertigo accounted for almost a quarter (24%) of dizziness/vertigo cases in the 
community. The study confirmed previous findings of a marked female preponderance among 
individuals with vertigo (one-year prevalence ratio male to female 1:2.7), and showed that vertigo is 
almost three times more frequent in the elderly compared with the young (Fig. 1).  
 
 
Personal and Occupational Impact of Vertigo 
 
Vertigo has a considerable personal impact. In the epidemiologic study from Germany described 
above, vertigo was recurrent in the vast majority of participants (88%) and caused severe impairment 
in 80% of affected individuals (i.e., it resulted in an interruption of daily activities, sick leave, or medical 
consultation). In addition, participants with vestibular vertigo had a lower ageand sex-adjusted health-
related quality of life compared with vertigo- and dizziness-free participants.12 Vertigo can cause 
psychiatric problems, which do not necessarily correlate with deficits on neurotologic testing. In a 
recent study, patients with vestibular neuritis and persistent vestibular deficits had lower levels of 
anxiety, depression, and somatization than patients with Ménière’s disease or vestibular migraine.13 
Of note, comorbid psychiatric symptoms in patients with organic otoneurologic disorders should be 
differentiated from somatoform otoneurologic symptoms, which include somatoform dizziness.14 
 
Little is known about the occupational impact of vertigo. Sick leave due to vestibular vertigo was 
reported by 41% of participants with vestibular vertigo working at the time, and by 15% of those with 
nonvestibular dizziness in a population-based study.12 In employees on long-term sick leave (more 
than 8 weeks), dizziness/ vertigo was a rather infrequent cause (0.9% of women and 0.7% of men) in 
a register-based prospective study from Norway.15 This corresponds to an annual incidence for 
women of 7.5 in 10,000 at risk (vocationally active) and for men of 3.2 in 10,000 at risk. One quarter of 
these women and men obtained a disability pension. However, most recurrent but nonchronic vertigo 
is unlikely to cause such long episodes of sickness leave, and the occupational impact of repeated 
short-term absence or more subtle productivity loss is unknown.  
 
Health Care Impact of Vertigo 
 
Vertigo and dizziness rank among the 10 most common reasons for referral to neurologists both in 
emergency rooms16 and in office-based settings.17 In the German neurotologic survey, vestibular 
vertigo accounted for 29% of dizziness/vertigo cases seen by a doctor. Overall, 70% of vertigo 
sufferers consulted a physician; however, more than half of participants with clear-cut vestibular 
vertigo were diagnosed with a nonvestibular disorder.12 The study also showed that 0.9% of 
unselected adults consulted a physician in the last 12 months for incident vestibular vertigo, that is for 
a new symptom that often leads to a costly diagnostic workup.12 Similarly, a recent Spanish primary 
care study found 7.6 per 1000 inhabitants (i.e., 0.8%) consulted in primary care over 12 months for 
incident vertigo defined as an illusion of unequivocal rotatory movement.18 The prevalence of 
primary care consultations for combined incident and recurrent vertigo was 1.8% over 12 months in 
the Spanish study.  
 
  
However, specific diagnoses are documented only rarely in dizziness/vertigo patients seen in primary 
care: more than 80% of 10,000 patients from a German primary care database were coded only as a 
symptom and not as specific diagnoses. Only 3.9% of dizziness/ 
vertigo patients were referred to specialists.19 Claims that dizziness/vertigo is a nonspecific symptom 
in a high proportion of patients, especially in old age, have been convincingly contradicted, for 
example, by a recent study showing that out of 3400 patients over 70 years of age an accurate 
diagnosis was possible in more than 75%. In these elderly patients, dizziness often had a multifactorial 
etiology and caused age-specific impairment, but dizziness caused by age per se was not found.20 
 
Dizziness and vertigo account for an increasing proportion of visits to emergency departments (ED), 
currently amounting to 2 to 3% of all consultations.21,22 In this setting, identification of central or 
otherwise serious vertigo is a major concern.22,23 However, stroke was found to be a rare cause of 
dizziness presentations to the ED in a recent population-based stroke surveillance study: only 0.7% of 
those presenting with isolated dizziness and 3.2% of those presenting with any dizziness had an acute 
cerebrovascular cause.24 In EDs in the United States, where nearly 26 million ED visits for dizziness/ 
vertigo over a period of 10 years (1995–2004) have been estimated, a median of 3.6 diagnostic tests 
per patient were performed and 17% of patients had a computed tomography (CT) scan or magnetic 
resonance imaging (MRI).21 In summary, data from primary care and from EDs show that 
misdiagnosis of vertigo and dizziness is common,3–6,25 and suggest that appropriate training for 
these disorders may benefit patients and save costs.  
 
 
Risk Factors for Vertigo  
 
Vertigo can be a symptom of a variety of conditions with different etiologies. Therefore, the potential 
benefit of investigating risk factors for the symptom vertigo is limited, and findings must be interpreted 
cautiously. However, some interesting insights have resulted from such studies, the most prominent 
being the consistent association of vertigo and migraine,26–28 which has greatly contributed to the 
recognition of vestibular migraine as a distinct vestibular syndrome. Migraine is also statistically 
associated with BPPV29–31 and Ménière’s disease.32 However, the implications of these 
associations are not clear yet. Because migraine is more common in women, the association of 
migraine and specific vestibular disorders may partly explain the marked female preponderance 
among vertigo sufferers, which has also been consistently reported for specific vestibular disorders 
including BPPV,33 Me´nie`re’s disease,32 and vestibular migraine.28 Along that line, case series have 
suggested that premenstrual or drug-related hormonal changes may increase the risk of vestibular 
disorders,34,35 but this was not confirmed by two other large studies.11,36 
 
There is increasing evidence for an association of vertigo with depression11,37,38; however, the 
directionality of this association is not clear yet. A structured evaluation of 100 randomly selected 
communitydwelling individuals with vertigo showed a 20% prevalence of depressive symptoms.39 A 
recent study found that a previous psychiatric disorder is a strong predictor for the development of 
reactive psychiatric disorders in vestibular patients.40 A few studies suggest a link between vertigo 
and cardiovascular risk factors (for a summary, see Neuhauser et al11), but the evidence is insufficient 
to support an independent association in unselected individuals after taking potential confounders 
into account. Of note, overt cardiovascular disease was not significantly associated with vertigo after 
correcting for potential confounders.11 In particular, transient ischemic attacks (TIAs) and stroke 
presenting with monosymptomatic vertigo are rare at the population level.41 
 
 
Epidemiology of Vestibular Disorders 
 
Due to scarce epidemiologic data, it may be tempting to extrapolate the distribution and outcome of 
vestibular disorders from studies in specialized care settings. However, this approach may be 
misleading and has been compared with the story where several blind men feel a different part of an 
elephant’s body and each one gives an accurate but biased account about what the elephant is like.42 
For example, the relative frequency of Ménière’s disease of 5 to 11% in specialized care 
settings28,43,44 is almost certainly due to selection bias, and considerably overestimates the 





Benign Paroxysmal Positional Vertigo  
 
Benign paroxysmal positional vertigo deserves special attention among vestibular disorders because it 
is not only the most frequent cause of recurrent vertigo, but it is also amenable to successful and 
inexpensive treatment by liberatory maneuvers.45 However, the importance of BPPV at the population 
level is still underestimated due to low recognition rates in primary care3,6 and scarce epidemiologic 
data. Two older studies that estimated the incidence of BPPV at 0.01% in Japan46 and 0.06% in 
Olmsted County, Minnesota,47 were based on recorded clinical cases and thus likely to considerably 
underestimate the incidence at the population level. A strikingly higher finding of 9% positive Dix–
Hallpike tests in a series of 100 geriatric clinic patients suggested that BPPV may be much more 
common in the community than previously thought.48 In a recent study of 38 unselected patients with 
a diagnosis of ‘‘dizziness’’ in primary care consultation, 40% had both typical symptoms of BPPV and 
a positive Dix–Hallpike test.6 Population-based epidemiologic data have been obtained from the 
nationally representative neurotologic survey conducted in Germany.4 Diagnostic criteria for BPPV 
were at least five attacks of vertigo lasting less than one minute without concomitant neurologic 
symptoms and invariably provoked by typical changes of head position (i.e., lying down, turning over in 
the supine position or at least two of the following maneuvers: reclining the head, rising up from supine 
position, and bending forward). The lifetime prevalence of BPPV was estimated at 2.4%, the 1-year 
prevalence at 1.6%, and the 1-year incidence at 0.6%. Of note, BPPV diagnoses relied on 
neurotologic interviews and not on positioning maneuvers, but the prevalence estimates are likely to 
be rather conservative because diagnostic criteria emphasized specificity and not sensitivity (the 
interviews had a specificity of 92% and a sensitivity of 88% in a concurrent validation study). Benign 
paroxysmal positional vertigo can manifest from childhood to a very old age with a reported peak age 
of onset in the sixth decade for idiopathic BPPV and a lower mean age of onset in secondary 
BPPV.49 The one-year prevalence of individuals with BPPV attacks (new-onset and recurrent) rises 
steeply with age: from 0.5% in 18 to 39 year olds, to 3.4% in individuals over 60 years of age.4 The 
cumulative (lifetime) incidence of BPPV reaches almost 10% by the age of 80.4 A recent clinical study 
reported a mean spontaneous remission time of untreated BPPV episodes of 39 days for posterior 
canal BPPV and 16 days for horizontal canal BPPV,50 a difference that is linked to the anatomic 
orientation of the canals. In the community, however, untreated episodes appear to be shorter, as 
suggested by a median episode duration of 2 weeks among 80 mostly untreated community-sampled 
individuals with BPPV (this study did not differentiate the affected canals).4 Most recurrences occur in 
the first year, and the cumulative recurrence rate is 50% at 3 to 5 years.51,52 A higher recurrence rate 
has been reported in traumatic BPPV compared with idiopathic BPPV53 and in women,51 but data on 
determinants of recurrences are still scarce.  
 
At present, the mechanisms of BPPV may be explained by canalolithiasis and cupulolithiasis. 
However, the underlying causes that lead to detachment of otoconia from the utricle are still poorly 
understood in the vast majority of patients. Head trauma and inner ear diseases, such as vestibular 
neuritis and Ménière’s disease, are probably less frequent causes than previously thought, accounting 
for 6% of unselected BPPV cases.4,54 More women than men are affected by BPPV (female:male 
ratio 1.5 to 2.2:1),4,33,46 but this seems to be the case only for idiopathic and not for secondary 
BPPV.55 This female preponderance is still poorly understood pathophysiologically, but may be linked 
to an equally poorly understood association of BPPV and migraine.29–31 Osteoporosis, which is more 
frequent in middle-aged and elderly women with BPPV compared with controls,56 may also play a 
role. Recent studies have found associations of BPPV with diabetes57 and with hypertension, 
hyperlipidemia, and stroke,4 but these observations await replication.  
 
There is also increasingly more evidence of adverse psychosocial consequences of BPPV, including 
reduced health-related quality of life,58 severe subjective impairment in affected individuals,3,4 and 
avoidance behavior in 70% of BPPV sufferers.4 Medical advice is sought by 80% of BPPV sufferers,4 
but specific diagnostic positioning maneuvers are applied in less than a third of patients seeking 
medical care. The rate of adequate therapy is even lower with only 10 to 20% of BPPV cases seen by 












Vestibular migraine is the second most common cause of recurrent vertigo after BPPV,28,59 but is 
only starting to be perceived as a nosologic entity by the medical community. Various terms, including 
migraine-associated vertigo, migraine-associated dizziness, migraine-related vestibulopathy, 
vestibular migraine, and benign recurrent vertigo have all been applied to roughly the same patient 
population. Vestibular migraine has been convincingly advocated as a term that stresses the particular 
vestibular manifestation of migraine, and thus best avoids confounding with nonvestibular dizziness or 
motion sickness associated with migraine. The term basilar migraine is restricted to patients who fulfill 
the diagnostic criteria of the International Headache Society (IHS)60 for basilar migraine, which 
applies to only _10% of patients with vestibular migraine.28,59,61 Interestingly, the awareness of a 
causal link between vertigo and migraine was promoted by epidemiologic observations indicating a 
more than chance association of migraine with vertigo and dizziness and not by pathophysiologic 
hypotheses.26–28,62 Vestibular migraine accounts for 6 to 7% of patients in neurologic dizziness 
clinics,28,59 and has been found in 9% of patients in a migraine clinic case series.28 Of note, 
dizziness was reported in over 70% of consecutive migraineurs,63 but can have various causes other 
than vestibular migraine.64 In the general population, migraine headaches and vestibular vertigo 
concur about three times more often than would be expected by chance. Lifetime prevalences are 
14% for migraine65 and 7% for vestibular vertigo.11 Thus, chance concurrence of the two would be 
1%, but the German neurotologic survey showed it to be 3.2%.5 This survey estimated the prevalence 
of definite vestibular migraine in the general adult population based on validated neurotologic 
interviews,11 and previously proposed explicit diagnostic criteria28 that require not only a migraine 
diagnosis according to the International Headache Society criteria,60 but also that migraine symptoms 
such as migrainous headache, photophobia, phonophobia, or migrainous auras occur concurrently 
with spontaneous vertigo attacks. The lifetime prevalence of vestibular migraine was 0.98% (95% CI 
0.70–1.37) and the 12-month prevalence 0.89 (95% CI 0.62–1.27).5 This study did not investigate 
probable vestibular migraine, which is a more sensitive but less specific diagnostic category than 
definite vestibular migraine requiring spontaneous vertigo attacks not attributable to another cause, 
and either a history of migraine or concurrence of migraine symptoms during vertigo.28 An even 
broader term is benign recurrent vertigo (BRV),66 which describes recurrent spontaneous attacks of 
vertigo that do not lead to permanent deficits and which cannot be attributed to a specific cause (other 
than migraine). The population prevalence of probable vestibular migraine and BRV are not known; 
however, a recent large case series of 208 patients with BRV comprised 61% with definite vestibular 
migraine, 29% with probable vestibular migraine, and 10% for which only the broadest term of BRV 
applied.67 These rates confirm expert opinion that vestibular migraine is a frequent condition both at 
the population level and in dizziness clinics.  
 
Vestibular migraine may occur at any age.59,61 The prevalence of recurrent vertigo probably related 
to migraine is estimated at 2.8% of children between ages 6 and 12.68 Benign paroxysmal vertigo of 
childhood, an early manifestation of vestibular migraine, is the most common diagnosis in children 
presenting with vertigo, followed by BPPV.69 In adults with vestibular migraine, there is a clear female 
preponderance with a reported female-to-male ratio between 1.5 and 5 to 1.28,59,61 However, a 
recent study reported that among unselected vestibular migraine sufferers there are not significantly 
more women than among dizziness-free migraineurs.5 In most patients, migraine headaches begin 
earlier in life than vestibular migraine,5,28,59 but little is known about the determinants of vestibular 
migraine. A comparison of patients with vestibular migraine with dizziness-free migraineurs showed an 
independent association with coronary heart disease, but not with sex, age, migrainous aura, 
education, stroke, hypertension, hyperlipidemia, body mass index, or depression.5  
 
The natural course of vestibular migraine is not well known, but disease severity has been reported to 
vary over time.70 However, the impact of vestibular migraine both at the personal and health care 
level may be considerable, as indicated by lower health-related quality of life scores in vestibular 
migraine patients compared with dizziness-free controls,5 higher levels of anxiety and depression in 
vestibular migraine patients compared with patients with persistent vestibular deficits, 13 and an 









Vestibular Neuritis  
 
The scarcity of epidemiologic data on vestibular neuritis, one of the most severely impairing acute 
vestibular disorders, is remarkable. Vestibular neuritis is likely to be a frequent cause of vertigo 
because it accounts for 3 to 10% of diagnoses in specialized dizziness clinics,28,43,71 and was 
reported to be the second most common dizziness diagnosis in general practice after BPPV.72 
However, the only published estimate on the frequency of vestibular neuritis in the general population 
comes from a government report in Japan, stating that vestibular neuritis occurs in 3.5 per 100,000 
inhabitants (although this is not further specified, one can assume that this is a one-year incidence).73 
The methods are not described, but based on the epidemiologic data on other vestibular disorders 
from this report, considerable underestimation of the frequency of vestibular neuritis in the population 
is likely. Data of the National Hospital Discharge Registry in Germany document 19,828 cases of 
vestibular neuronitis in 2006 (www.who.int/classifications/icd/en ), corresponding to 24 per 100,000 
inhabitants (personal communication, German National Statistical Office). Also from Japan originates 
the single largest published series of _600 patients aged 3 to 88 years with a peak of age distribution 
between 30 
and 50. There was no female preponderance as in other vestibular disorders, but on the contrary, a 
male predominance until the age of 40.73 The recurrence rate was as low as 1.9% in a follow-up study 
with a follow-up period of 5 to 20 years.74 However, the long-term outcome of vestibular neuritis may 
not be as favourable as previously thought because persisting dizziness has been reported in 30 to 
40% of patients75,76 and chronic anxiety in 15%.77 However, complete long-term recovery has been 





Vertigo and cochlear disturbances are common in the general population and when patients present 
with both, Ménière’s disease is frequently suspected. Ménière’s disease accounts for 3 to 11% of 
diagnoses in dizziness clinics,28,43,71 but this reflects selection bias in specialized care settings 
toward severe, recurrent, and difficult to treat vestibulopathies. In the general population, Me´nie`re’s 
disease is a rare disease; therefore, reliable prevalence and incidence estimates are difficult to obtain. 
Most studies have been based on patient registers and have various methodological restrictions (for a 
summary see Kotimäki et al79). A thorough reevaluation of Ménière’s disease diagnoses from the 
Mayo Clinic’s Centralized Diagnostic Index in Rochester, according to the previous criteria of the 
American Academy of Ophthalmology and Otolaryngology (AAOO, 1972), resulted in an estimated 
annual incidence rate of 15 per 100,000 and a point prevalence of 218 per 100,000 population, which 
is higher than previous estimates.80 Because Me´nie`re’s disease is a rare disease, the prevalence is 
reported per 100,000 population; however, for comparison the estimated 218 per 100,000 correspond 
to 0.2%, that is eight times less common than BPPV. Furthermore, in the Rochester study, only 65% 
had classic Ménière’s  disease, while 26% had vestibular Ménière’s, and 9% had cochlear Ménière’s, 
two variants that were included in the 1972 AAOO criteria, but no longer fulfill the 1995 diagnostic 
criteria for Ménière’s disease of the American Academy of Otolaryngology-Head and Neck Surgery 
(AAO-HNS).2  
 
Recently, a prevalence of 513 per 100,000 was reported from southern Finland, which is considerably 
higher than figures from previous studies.10 The study was based on a questionnaire sent to a sample 
of the general population inquiring about vertigo, hearing loss, and tinnitus, and a review of available 
medical records. The 1995 AAO criteria were used, but the published questionnaire suggests that the 
hearing loss and duration criteria may have been modified. Interestingly, the number 
of individuals who reported that they suffer from impaired hearing and tinnitus, and in addition 
experienced vertigo at some point in the past, was 14 times higher than the number of Ménière’s 
disease cases. This illustrates that when a patient presents with one of the three symptoms of vertigo, 
hearing loss, and tinnitus, and reports the two others at some point in the past, the probability of 
Ménière’s disease is still rather low and more specific information is required before suspecting 
Ménière’s disease. In medical practice, Ménière’s disease is overdiagnosed, as suggested by both the 
Rochester study and a more recent Finish study, which applied the AAOO and AAO-HNS criteria, 
respectively, and confirmed only 40% of Ménière’s disease diagnoses suspected in primary care.79,80 
 
Generally, Ménière’s disease is regarded as a disease of the middle-aged, which can occasionally 
occur in children. However, Ménière’s disease is not uncommon after 65 years of age, accounting for 
15% of a large case series.81 A female preponderance can be assumed based on the data from 
  
Rochester (61% women)80 and is confirmed by the latest data from Finland.10 Bilateral disease was 
present in 19% in a recent large case series.82 The majority of patients (59%) with bilateral Ménière’s 
disease developed second-ear symptoms in less than 6 months from onset, but there was also a 
group with late onset of second ear symptoms (average 14 years, range 1 to 27 years). The debate on 
the multiple etiologic possibilities of Ménière’s disease is ongoing. An intriguing finding is the increased 
prevalence of migraine in Ménière’s disease patients.32 In a recent study, Ménière’s disease patients 
had an earlier onset of symptoms and a greater susceptibility to bilateral hearing loss when they also 
had migraine.83 However, a frequent occurrence of migrainous symptoms during Ménière’s disease 
attacks has been found, which may reflect some overlap between the diagnostic criteria for Ménière’s 
disease and for vestibular migraine32 or a shared genetic susceptibility.84 Inhalant and food allergies 





Epidemiologic findings on the distribution, determinants, and outcome of vertigo can contribute both to 
better patient care and to a better understanding of the underlying causes of vestibular disorders. 
Epidemiologic observations of the association between migraine and vertigo are a good example. 
However, the epidemiology of vertigo and vestibular disorders is still an underdeveloped field. In 
particular, prevalence and outcome studies are frequently hampered by selection bias due to patient 
identification in specialized care settings. Recent studies have underscored the high frequency and 
impact of the symptom vertigo and of vestibular disorders at the population level, in particular BPPV 
and vestibular migraine, but the determinants and outcome of these frequent conditions are not well 
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Table 1 Prevalence and Incidence of Dizziness and Vertigo of Moderate/Severe Intensity in the 
General Adult Population 
 






Figure 1 Twelve-month prevalence of vestibular vertigo in adults. (Based on data from Neuhauser et 
al.11) 
 
 
 
 
  
